The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2006
DOI: 10.1590/s1677-54492006000300015
|View full text |Cite
|
Sign up to set email alerts
|

Embolização intra-arterial pré-operatória de tumor do corpo carotídeo

Abstract: The authors report a case of carotid body tumor (paraganglioma) in a 74-year-old male patient, submitted to intraarterial embolization with spherical core/shield polyvinyl acetate and polyvinyl alcohol (PVAc + PVA) microparticles prior to surgical excision. Angiography has demonstrated a highly vascularized mass in the left carotid bifurcation, and preoperative embolization was used in order to decrease vascularity, reduce blood loss and improve safety of surgical treatment. Microscopic study confirmed presenc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2012
2012

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 13 publications
(23 reference statements)
0
1
0
Order By: Relevance
“…An ideal embolic agent should provide a large number of features;23 however, biocompatibility and non‐carcinogenicity constitute basic requirements for any type of material used in biomedical applications. Although a relatively large number of materials have already been used as embolic agents,18, 19, 24–27 PVA‐based particles are certainly the most frequently used embolic agents, because of their characteristic biocompatibility and performance 19, 28–30. However, commercial PVA grades present some undesirable characteristics (e.g., irregular morphology) that make these commercial PVA grades unsuited for use as embolic agents 21…”
Section: Introductionmentioning
confidence: 99%
“…An ideal embolic agent should provide a large number of features;23 however, biocompatibility and non‐carcinogenicity constitute basic requirements for any type of material used in biomedical applications. Although a relatively large number of materials have already been used as embolic agents,18, 19, 24–27 PVA‐based particles are certainly the most frequently used embolic agents, because of their characteristic biocompatibility and performance 19, 28–30. However, commercial PVA grades present some undesirable characteristics (e.g., irregular morphology) that make these commercial PVA grades unsuited for use as embolic agents 21…”
Section: Introductionmentioning
confidence: 99%